Richard Newitter
Stock Analyst at Truist Securities
(4.06)
# 530
Out of 5,138 analysts
442
Total ratings
51.32%
Success rate
12.16%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PEN Penumbra | Downgrades: Hold | $370 → $374 | $355.44 | +5.22% | 8 | Jan 16, 2026 | |
| INSP Inspire Medical Systems | Maintains: Buy | $165 → $120 | $94.45 | +27.05% | 30 | Jan 8, 2026 | |
| IRTC iRhythm Holdings | Maintains: Buy | $230 → $215 | $165.60 | +29.83% | 19 | Dec 18, 2025 | |
| VCEL Vericel | Maintains: Buy | $50 → $45 | $36.29 | +24.00% | 6 | Dec 18, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Hold | $4 → $3 | $2.60 | +15.61% | 19 | Dec 18, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Hold | $17 → $24 | $20.49 | +17.13% | 4 | Dec 18, 2025 | |
| SYK Stryker | Maintains: Hold | $400 → $392 | $359.61 | +9.01% | 25 | Dec 18, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $50 → $47 | $30.31 | +55.06% | 16 | Dec 18, 2025 | |
| MDT Medtronic | Maintains: Hold | $110 → $107 | $98.60 | +8.52% | 19 | Dec 18, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $80 → $82 | $65.88 | +24.47% | 22 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $620 → $650 | $527.44 | +23.24% | 32 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $86 → $95 | $85.15 | +11.57% | 12 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $412 → $390 | $284.25 | +37.20% | 4 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $145 | $123.45 | +17.46% | 7 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $120 | $91.20 | +31.58% | 20 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $37 | $18.43 | +100.76% | 5 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $90 → $92 | $83.46 | +10.23% | 22 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $93 → $105 | $92.95 | +12.96% | 30 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 → $20 | $12.68 | +57.73% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $94 → $82 | $70.73 | +15.93% | 3 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $13 → $15 | $12.01 | +24.90% | 19 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $137 | $100.34 | +36.54% | 38 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $24 | $18.42 | +30.29% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $86.80 | +30.18% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $21 | $16.94 | +23.97% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $9.66 | +107.04% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $79.06 | +3.72% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $203.39 | +22.92% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $3.71 | +600.81% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $165.55 | +365.12% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $75.11 | +13.17% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $12.00 | +66.67% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $31.87 | -15.28% | 5 | Feb 23, 2021 |
Penumbra
Jan 16, 2026
Downgrades: Hold
Price Target: $370 → $374
Current: $355.44
Upside: +5.22%
Inspire Medical Systems
Jan 8, 2026
Maintains: Buy
Price Target: $165 → $120
Current: $94.45
Upside: +27.05%
iRhythm Holdings
Dec 18, 2025
Maintains: Buy
Price Target: $230 → $215
Current: $165.60
Upside: +29.83%
Vericel
Dec 18, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $36.29
Upside: +24.00%
Treace Medical Concepts
Dec 18, 2025
Maintains: Hold
Price Target: $4 → $3
Current: $2.60
Upside: +15.61%
Tandem Diabetes Care
Dec 18, 2025
Maintains: Hold
Price Target: $17 → $24
Current: $20.49
Upside: +17.13%
Stryker
Dec 18, 2025
Maintains: Hold
Price Target: $400 → $392
Current: $359.61
Upside: +9.01%
PROCEPT BioRobotics
Dec 18, 2025
Maintains: Buy
Price Target: $50 → $47
Current: $30.31
Upside: +55.06%
Medtronic
Dec 18, 2025
Maintains: Hold
Price Target: $110 → $107
Current: $98.60
Upside: +8.52%
Lantheus Holdings
Dec 18, 2025
Maintains: Buy
Price Target: $80 → $82
Current: $65.88
Upside: +24.47%
Dec 18, 2025
Maintains: Buy
Price Target: $620 → $650
Current: $527.44
Upside: +23.24%
Dec 18, 2025
Maintains: Buy
Price Target: $86 → $95
Current: $85.15
Upside: +11.57%
Dec 18, 2025
Maintains: Buy
Price Target: $412 → $390
Current: $284.25
Upside: +37.20%
Dec 18, 2025
Maintains: Buy
Price Target: $120 → $145
Current: $123.45
Upside: +17.46%
Dec 18, 2025
Maintains: Buy
Price Target: $130 → $120
Current: $91.20
Upside: +31.58%
Dec 18, 2025
Maintains: Buy
Price Target: $32 → $37
Current: $18.43
Upside: +100.76%
Dec 5, 2025
Maintains: Hold
Price Target: $90 → $92
Current: $83.46
Upside: +10.23%
Nov 18, 2025
Reiterates: Buy
Price Target: $93 → $105
Current: $92.95
Upside: +12.96%
Nov 7, 2025
Reiterates: Buy
Price Target: $18 → $20
Current: $12.68
Upside: +57.73%
Nov 3, 2025
Reiterates: Buy
Price Target: $94 → $82
Current: $70.73
Upside: +15.93%
Oct 15, 2025
Maintains: Hold
Price Target: $13 → $15
Current: $12.01
Upside: +24.90%
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $100.34
Upside: +36.54%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $24
Current: $18.42
Upside: +30.29%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $86.80
Upside: +30.18%
Jan 31, 2023
Maintains: Buy
Price Target: $17 → $21
Current: $16.94
Upside: +23.97%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $9.66
Upside: +107.04%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $79.06
Upside: +3.72%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $203.39
Upside: +22.92%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $3.71
Upside: +600.81%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $165.55
Upside: +365.12%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $75.11
Upside: +13.17%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $12.00
Upside: +66.67%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $31.87
Upside: -15.28%